3rd Balkan and Eastern European Masterclass in Clinical Oncology
30 ESCO credits
08.05.2013 - 12.05.2013
Dubrovnik, Croatia
MASTERCLASS
Description
Chair: R. Popescu, CH/RO
Co-Chair: S. Beslija, BA
AIMS AND OBJECTIVES
This clinically oriented residential educational programme has been designed for dedicated physicians wishing to improve their skills in the management of cancer patients.
The 3rd Balkan and Eastern European Masterclass is dedicated to clinicians who are specifically and almost exclusively dedicated to medical oncology, radiation oncology and surgical oncology (breast and colon). The programme will expose participants to a full spectrum of issues in clinical oncology and to practice-orientated training. The programme focuses on lung, GI and breast cancers.
TEACHING FORMAT
The Masteclass offers plenary lectures regarding the state-of-the-art clinical evaluation and treatments with reference to clinical guidelines and which conclude in taking-home messages. Furthermore, practical training will be offered in the frame of clinical case presentations prepared and presented by the faculty and participants for an interactive discussion.
All participants will reside at the masterclass venue and participation is compulsory throughout the course.
The Masterclass will be entirely in English and fluency in English is necessary for admission.
THE MASTERCLASS IS:
• A 3-day residential educational event
• Full immersion
• Clinically-oriented
• Multidisciplinary
• An international faculty of experts delivering lectures focusing on lung, GI and breast cancers
The 3rd Balkan and Eastern European Masterclass in Clinical Oncology is an ESMO supported meeting | | |||
General information
ORGANISING SECRETARIAT
Roberta Ventura
European School of Oncology (ESO)
Via Turati, 29
20121 Milan, Italy
Tel: +39 02 8546 4532
Fax: +39 02 8546 4545
Email: balkans@eso.net
VENUE
Radisson Blu Resort & SPA
Dubrovnik Sun Gardens
Na Moru 1
Orašac Dubrovnik, Croatia
Tel: +385 20 361 500
Fax: +385 20 361 501
www.radissonblu.com/resort-dubrovnik
ACCREDITATION
The 3rd Balkan and Eastern European Masterclass in Clinical Oncology is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net.
The 3rd Balkan and Eastern European Masterclass in Clinical Oncology is designated for up to 20 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.
The programme is furthermore accredited with 15 ESMO-MORA cat. 1 points.
Faculty list
FACULTY
S. Beslija, Institute of Oncology, Clinical Center Sarajevo University, Sarajevo, BA
F. Cavalli, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
D. Cortinovis, S. Gerardo Hospital, Monza, IT
A. Costa, European School of Oncology, Milan, IT
G. Cserni, Bacs Kiskun County Teaching Hospital, Kecskemet, HU
T. Cufer, University Clinic Golnik, SI
A. Eniu, Cancer Institute "I. Chiricuta", Cluj-Napoca, RO
D. Jovanovic, Institute for Lung Disease, Clinical Center of Serbia, Belgrade, RS
A. Juretic, School of Medicine, University of Zagreb and Clinical Hospital Center Zagreb, HR
I. Kern, University Clinic of Pulmonary and Allergic Disease, Golnik, SI
R. Popescu, Hirslanden Klinik Aarau, CH/RO
J. Souglakos, University Hospital of Heraklion , Crete, GR
M. Sporis, Clinical County Hospital, Hospice “Casa Sperantei”, Brasov, RO
E. Vrdoljak, Clinical Hospital Split, Medical School Split, HR
J. Zgajnar, Institute of Oncology, Ljubljana, SI
Programme
8 May
18:30 | Welcome address and general introduction |
20:00 | Dinner |
9 May
LUNG CANCER | |
8:00 | Pathology and molecular biology of lung cancer |
8:20 | Diagnostic procedures, staging and surgery of lung cancer D. Jovanovic, RS |
9:00 | Combined chemo-radiotherapy in lung cancer |
9:45 | Coffee break |
10:15 | Adjuvant/neoadjuvant systemic therapy in NSCLC T. Cufer, SI |
11:00 | Systemic therapy for advanced NSCLC D. Cortinovis, IT |
12:00 | Systemic therapy for SCLC D. Cortinovis, IT |
13:00 | Lunch |
15:30-18:00 Case presentations and discussions with interactive voting Panellists: I. Kern, SI - D. Jovanovic, RS - A. Juretic, HR - T. Cufer, SI - D. Cortinovis, IT | |
18:15 | e-grandround “New targeted therapies and their cost effectiveness” Expert: I. Tannock, Princess Margaret Hospital, Toronto, CA Discussant: M. Hutka, Royal Marsden Hospital, Sutton, UK |
20:00 | Dinner |
10 May
GI CANCERS | |
8:00 | Pathology of colorectal and gastric cancer |
8:30 | Systemic therapy for advanced colorectal cancer R. Popescu, CH/RO |
9:20 | Optimal therapy for colorectal cancer with liver metastases J. Souglakos, GR |
10:10 | Adjuvant chemotherapy for colorectal cancer: key messages J. Souglakos, GR |
10:30 | Coffee break |
11:00 | Rectal cancer treatment E. Vrdoljak, HR |
12:00 | Gastric and pancreatic cancer: key messages |
13:00 | Lunch |
14:00-16:00 Case presentations and discussions with interactive voting Panellists: G. Cserni, HU - R. Popescu, CH/RO - J. Souglakos, GR E. Vrdoljak, HR | |
16:45 | Transfer from the Hotel to Dubrovnik old town |
20:00 | Transfer from Dubrovnik old town to the hotel |
20:30 | Dinner |
11 May
BREAST CANCER | |
8:00 | Pathology of breast cancer. Epidemiology in the Balkan region G. Cserni, HU |
8:30 | Principles of surgery and radiotherapy for breast cancer J. Zgajnar, SI |
9:00 | Principles of adjuvant chemotherapy and anti her2 treatment-issues on availability A. Eniu, RO |
9:45 | Principles of adjuvant hormonal therapy for pre-and postmenopausal breast cancer patients |
10:30 | Coffee break |
BREAST CANCER | |
11:00 | Principles of systemic neoadjuvant treatment (chemotherapy, antiHer2, hormonal) for locally advanced disease |
11:30 | Principles of treatment of metastatic disease: hormonal and chemotherapy treatment |
12:30 | Principles of treatment of metastatic disease: anti-Her2 treatment S. Beslija, BA |
13:15 | Lunch |
15:30-18:00 Case presentations and discussions with interactive voting | |
18:15- | Occupy Oncology: a report from the World Oncologic Forum F. Cavalli, CH |
20:00 | Dinner |
12 May
| PALLIATIVE CARE |
8:30 | Palliative care |
9:30 | Discussion and open questions (present faculty) |
10:00 | Closure R. Popescu, CH/RO |